

Other version: http://informahealthcare.com/doi/abs/10.1080/00365540210147642
![]() |
Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole |
|
Authors | ||
Published in | Scandinavian journal of infectious diseases. 2002, vol. 34, no. 9, p. 701-703 | |
Abstract | Paecilomyces lilacinus is a rare cause of endophthalmitis and there are few reports of it in the literature. Herein we report a patient with P. lilacinus endophthalmitis who was treated with the new triazole, voriconazole, for 4 months, with a good clinical evolution. This treatment appears to be a valuable new therapeutic option but requires further clinical confirmation. | |
Keywords | Adolescent — Adult — Aged — Antifungal Agents/ therapeutic use — Endophthalmitis/ drug therapy — Female — Humans — Male — Middle Aged — Mycoses/ drug therapy — Paecilomyces/ isolation & purification — Pyrimidines/ therapeutic use — Triazoles/ therapeutic use | |
Identifiers | PMID: 12374371 | |
Full text |
![]() ![]() Other version: http://informahealthcare.com/doi/abs/10.1080/00365540210147642 |
|
Structures | ||
Citation (ISO format) | GARBINO, Jorge et al. Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. In: Scandinavian journal of infectious diseases, 2002, vol. 34, n° 9, p. 701-703. https://archive-ouverte.unige.ch/unige:7254 |